Combined Rotational excimer lASER coronary atherectomy (RASER) in non-crossable, non-dilatable coronary artery disease: observations from a single center
- PMID: 38377536
- DOI: 10.25270/jic/23.00267
Combined Rotational excimer lASER coronary atherectomy (RASER) in non-crossable, non-dilatable coronary artery disease: observations from a single center
Abstract
Background: Balloon non-crossable stenoses represent a challenging subset of coronary artery disease (CAD). They are clinically associated with patients who are older, frailer, and with multi-morbidities, and angiographically with increased tortuosity and coronary artery calcification. Combined rotational (RA) excimer laser coronary atherectomy (ELCA), or RASER, may facilitate stent delivery and deployment in non-crossable, non-dilatable severely calcified lesions. In this study, we assessed preliminary safety and efficacy of the RASER hybrid technique.
Methods: RASER feasible percutaneous coronary intervention (PCI) procedures performed at a large tertiary hospital in the northeast of England were retrospectively analyzed from September 1, 2008, to February 28, 2022. Major endpoints were in-hospital death from any cause, as well as procedural and angiographic success, defined by stent delivery with less than 50% residual stenosis and without clinical or angiographic complications, respectively.
Results: From 74 unique cases, there were 28 RASER, 24 ELCA/RA, 16 balloon angioplasty ± stenting, and 6 medically treated patients. In-hospital mortality rate was 5.2%, including 1 ELCA- and 3 RASER-treated patients. Successful stent delivery was achieved in significantly more RASER-treated patients compared to ELCA/RA- or balloon-treated patients: 96.4% (27/28), 25% (6/24), and 31.3% (5/16) respectively (P less than .001).
Conclusions: In our retrospective, single-center study, patients with CAD who were deemed appropriate for RASER PCI had a high peri-procedural mortality rate. In this context, adjunctive RASER therapy provides acceptable safety and efficacy as a bailout strategy, with at least 3 out of 5 patients achieving satisfactory procedural and angiographic results. Randomized controlled trials are needed to comprehensively compare the clinical outcomes of high-risk RASER PCI vs conservative medical therapy.
Keywords: calcification; coronary artery disease; excimer laser coronary atherectomy; mortality; percutaneous coronary intervention; rotational atherectomy.
Similar articles
-
Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.Catheter Cardiovasc Interv. 2021 Jun 1;97(7):E911-E918. doi: 10.1002/ccd.29377. Epub 2020 Nov 17. Catheter Cardiovasc Interv. 2021. PMID: 33201601
-
Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions.EuroIntervention. 2013 Jun 22;9(2):243-50. doi: 10.4244/EIJV9I2A40. EuroIntervention. 2013. PMID: 23454891
-
Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: The ROLLER COASTR-EPIC22 Trial.JACC Cardiovasc Interv. 2025 Mar 10;18(5):606-618. doi: 10.1016/j.jcin.2024.11.012. Epub 2025 Feb 5. JACC Cardiovasc Interv. 2025. PMID: 39918495 Clinical Trial.
-
Excimer Laser Atherectomy in Percutaneous Coronary Intervention: A Contemporary Review.Cardiovasc Revasc Med. 2021 Apr;25:75-85. doi: 10.1016/j.carrev.2020.10.016. Epub 2020 Oct 27. Cardiovasc Revasc Med. 2021. PMID: 33158754 Review.
-
Rotational atherectomy for left main coronary artery disease in octogenarians: transradial approach in a tertiary center and literature review.J Interv Cardiol. 2013 Apr;26(2):173-82. doi: 10.1111/joic.12026. J Interv Cardiol. 2013. PMID: 23557587 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous